Statement of Comprehensive Income
Difficulty: Beginner
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Pfizer Inc., Consolidated Statement of Comprehensive Income
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income before allocation to noncontrolling interests | 21,355 | 7,246 | 6,986 | 9,168 | 22,072 | ||||||
| Foreign currency translation adjustments | 1,493 | (800) | (3,200) | (2,096) | (502) | ||||||
| Derivative financial instruments | (378) | (73) | (96) | 438 | 240 | ||||||
| Available-for-sale securities | 532 | 96 | (5) | (372) | (86) | ||||||
| Actuarial gains (losses) | 211 | (740) | 921 | (2,432) | 2,887 | ||||||
| Prior service (costs) credits and other | (128) | (1) | 148 | 420 | 54 | ||||||
| Benefit plans | 83 | (741) | 1,069 | (2,012) | 2,941 | ||||||
| Other comprehensive income (loss) before allocation to noncontrolling interests | 1,730 | (1,518) | (2,232) | (4,042) | 2,593 | ||||||
| Comprehensive income before allocation to noncontrolling interests | 23,085 | 5,728 | 4,754 | 5,126 | 24,665 | ||||||
| Comprehensive (income) loss attributable to noncontrolling interests | (62) | (27) | 1 | (36) | (7) | ||||||
| Comprehensive income attributable to Pfizer Inc. | 23,023 | 5,701 | 4,755 | 5,090 | 24,658 |
Based on: 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-28).
| Item | Description | The company |
|---|---|---|
| Net income attributable to Pfizer Inc. | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Pfizer Inc.'s net income attributable to Pfizer Inc. increased from 2015 to 2016 and from 2016 to 2017. |
| Comprehensive income attributable to Pfizer Inc. | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | Pfizer Inc.'s comprehensive income attributable to Pfizer Inc. increased from 2015 to 2016 and from 2016 to 2017. |